MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > Medmira

<< Previous

Bullboard Posts

Next >>

Comment by august202013on Aug 06, 2021 2:02am

269 Views

Post# 33662174

RE:Medmira

ROSSAPORINO if scroll down that publication is dated FEBRUARY 2020 and recently USA FDA has even WITHDRAWN the EUA for most of these companies including for MEDMIRA. Off course ABBOTT being a USA Company theirs are ok. As for MEDMIRA they have resubmitted the new one for COVID19 TEST KIT PLUS . So MEDMIRA can wait and wait and WAIT. But we can continue to wait.

<< Previous

Bullboard Posts

Next >>

AI companies to invest in